MARKET

XLRN

XLRN

Acceleron
NASDAQ

Real-time Quotes | Nasdaq Last Sale

40.97
-2.03
-4.71%
After Hours: 40.97 0 0.00% 16:35 11/15 EST
OPEN
43.33
PREV CLOSE
43.00
HIGH
43.33
LOW
40.78
VOLUME
507.33K
TURNOVER
--
52 WEEK HIGH
56.91
52 WEEK LOW
37.01
MARKET CAP
2.17B
P/E (TTM)
-15.2158
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XLRN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

XLRN News

  • Biotech Stock Roundup: SLDB Plunges, CELG Gets FDA Nod for Reblozyl & Other Updates
  • Zacks.3d ago
  • Edited Transcript of XLRN earnings conference call or presentation 6-Nov-19 3:00pm GMT
  • Thomson Reuters StreetEvents.5d ago
  • Celgene & Acceleron Get FDA Nod for Rare Blood Disorder Drug
  • Zacks.5d ago
  • Acceleron Pharma up 7% on FDA nod for luspatercept
  • seekingalpha.11/08 23:25

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About XLRN

Acceleron Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta), protein superfamily. It has four internally discovered therapeutic candidates that are in clinical trials, which include luspatercept, sotatercept, dalantercept and ACE-083. It offers a platform technology, IntelliTrap. It is also evaluating ACE-1332, a selective TGF-beta antagonist, for treatment of disorders with a fibrotic component, and additional molecules from its IntelliTrap platform for undisclosed therapeutic areas. Dalantercept is designed to treat cancers by inhibiting blood vessel formation by inhibiting signaling through the ALK1 receptor. ACE-083 is designed to promote muscle growth and function in specific, targeted muscles.
More

Webull offers Acceleron Pharma Inc (XLRN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.